Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis.

Yang L, Guo J, Kane-Gill SL, Gabriel N, Empey KM, Suh K, Kirisci L, Hernandez I.

Open source

DOI
10.1002/pds.70098
Published
2025-02-01
Container
Pharmacoepidemiol Drug Saf
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70098,
  title = {Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis.},
  author = {Yang L and  Guo J and  Kane-Gill SL and  Gabriel N and  Empey KM and  Suh K and  Kirisci L and  Hernandez I.},
  year = {2025},
  journal = {Pharmacoepidemiol Drug Saf},
  doi = {10.1002/pds.70098},
  url = {https://doi.org/10.1002/pds.70098}
}

RIS

TY  - JOUR
TI  - Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis.
AU  - Yang L
AU  -  Guo J
AU  -  Kane-Gill SL
AU  -  Gabriel N
AU  -  Empey KM
AU  -  Suh K
AU  -  Kirisci L
AU  -  Hernandez I.
PY  - 2025
JO  - Pharmacoepidemiol Drug Saf
DO  - 10.1002/pds.70098
UR  - https://doi.org/10.1002/pds.70098
ER  - 

APA

L, Y., J, G., SL, K., N, G., KM, E., K, S., L, K., & I., H. (2025). Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis.. Pharmacoepidemiol Drug Saf. https://doi.org/10.1002/pds.70098

Source records